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Introduction: Tumor necrosis factor alpha (TNFα) plays a physiological role in controlling synaptic transmission and
plasticity in the healthy central nervous system by modulating glutamate receptor trafficking to the plasma membrane.
TNFα expression is also rapidly induced in response to tissue injury and infection. By promoting the insertion of Ca2+
permeable-AMPA receptors into the neuronal plasma membrane, this cytokine may cause excessive Ca2+ influx into
neurons, thus enhancing neuronal death.
Methods: Primary cultures of cortical neurons were obtained from E18 foetal mice and incubated for 24 h with adult
neural stem cells (aNPCs) either stimulated with lipopolysaccharide (LPS+aNPCs) or not (aNPCs). Cultures were treated
with TNFα (100 ng/ml), and electrophysiological recordings were performed in different conditions to evaluate the
effect of the cytokine on neuronal transmission.
Results: In this study, we demonstrate that aNPCs from the subventricular zone reverse the effects induced by the
cytokine. Moreover, we show that the effect of aNPCs on cortical neurons is mediated by cannabinoid CB1 receptor
activation.
Conclusion: These data suggest that the role of aNPCs in preventing excitatory neurotransmission potentiation
induced by TNFα on cortical neurons may have important implications for pathologies characterized by an
inflammatory component affecting cortical neurons such as Alzheimer’s disease.Introduction
The pro-inflammatory cytokine tumor necrosis factor
alpha (TNFα), released by glial cells, is involved in sev-
eral brain functions. Under physiological conditions,
the cytokine is thought to be responsible for the activity-
dependent homeostatic regulation of synaptic connectiv-
ity, which consists of the increase of synaptic strength in
response to prolonged blockade of activity. This process,
termed synaptic scaling, involves the insertion of AMPA
receptors, mobilized from intracellular stores, into the
plasma membrane [1–4].
However, because an excess of cell surface localized
AMPA receptors might predispose the neuron to
glutamate-mediated excitotoxicity and excessive intracel-
lular calcium concentrations, an increase in the amount of
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years, TNFα actions have been implicated consistently and
increasingly in central nervous system (CNS) pathology.
In particular, elevated TNFα levels have been reported in
multiple sclerosis, stroke, ischemia, and epilepsy [7–12]. A
crucial role of TNFα has also been reported in Alzheimer’s
disease (AD) [13]. More specifically, TNFα is upregulated
in patients with AD [14], and polymorphisms of the TNFα
gene affect the risk of developing AD [15].
Recent evidence has indicated that microglial TNFα
production plays a critical role in the induction of neur-
onal cell cycle events in AD, which are toxic for terminally
differentiated neurons and lead to neurodegeneration [16].
Consistent with a role of TNFα in AD, perispinal adminis-
tration of etanercept, a potent anti-TNF fusion protein,
produced sustained clinical improvement in a 6-month,
open-label pilot study in patients with mild to severe AD
(reviewed in [17]).
It has recently been found that adult neural stem/pre-
cursor cells (aNPCs) located within the subventricular
zone (SVZ) adapt their functions to the needs of theis distributed under the terms of the Creative Commons Attribution 4.0
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neurogenic roles aimed at the maintenance of brain
homeostasis, besides purely neurogenic functions [18]. In
chronic inflammatory conditions, NPCs seem to be driven
toward cell replacement, differentiating into new cellular
elements in order to replace lost endogenous cells. Con-
versely, in acute inflammatory conditions, NPCs tend to
remain undifferentiated and promote CNS tissue healing
via the secretion of immunomodulatory and neuroprotec-
tive molecules that are capable of reducing detrimental
tissue responses (reviewed in [19]). A continuous crosstalk
between immune cells and NPCs appears to determine
both the efficacy of endogenous regenerative responses
and mechanism of action as well as the fate and functional
integration of grafted NPCs, through different kinds of
receptors located on their membranes [20, 21].
The non-neurogenic function has been demonstrated in
stroke, where newly formed NPCs that were not inte-
grated into the neural network were shown to provide
protection from tissue injury via the secretion of neuro-
trophic factors [22, 23]. Additionally, NPCs have been re-
cently found to play an “innate” homeostatic regulatory
role, likely aimed at the prevention of reactive inflamma-
tion, by protecting striatal neurons from glutamate-
mediated excitotoxicity [24]. More specifically, SVZ-
derived aNPCs reverted the increased frequency and
duration of spontaneous excitatory post-synaptic currents
induced by exposure of striatal neurons to TNFα [24].
Whether the protective effect of aNPCs on striatal neu-
rons extends to different neuronal populations subjected
to pathological insults remains unknown. Given the
established pathological role of TNFα in different dis-
eases, we aimed at investigating whether SVZ-derived
aNPCs are able to revert the effects of this cytokine also
in cortical neurons, which represent the main target
cells for neurodegenerative processes such as those oc-
curring in Alzheimer’s disease.
Methods
Ethics statement
All the experimental procedures followed the guidelines
established by the Italian Council on Animal Care and
were approved by Italian Government decree 27/2010.
Cell cultures and drug treatments
Primary neuronal cultures from cerebral cortex were ob-
tained from E18 C57Bl/6 mice as described by Bartlett
and Banker (1984) [25] with slight modifications as in
[26]. Briefly, cortices were removed and dissociated by
treatment with trypsin (0.125 % for 15 min at 37 °C)
followed by trituration with a polished Pasteur pipette.
The dissociated cells were plated onto glass coverslips
coated with poly-L-lysine at a density of 400 cells/mm2.
The cells were maintained in Neurobasal medium(Waltham, MA USA 02451) with B27 supplement,
penicillin-streptomycin (10,000 units/ml), 2 mM glutam-
ine, and 12.5 μM glutamate (neuronal medium).
TNFα (100 ng/ml) was incubated with neurons for
30 min prior to electrophysiological recordings and was
present during the recordings [2], in the presence or ab-
sence of the neutralizing mouse TNF-α antibody (0.5 μg/
ml; R&D Systems, Minneapolis, MN, USA) to neutralize
the biological activity of mouse TNF-α. The cannabinoid
antagonist AM251 was added to the cortical neurons at
a final concentration of 5 μM for 2 h and was present
during recordings [27].
Generation and maintenance of aNPC cultures
aNPC cultures were obtained from 6-week-old C57Bl/6
mice, as previously described [28]. Briefly, 3-mm-thick
coronal sections were obtained from the anterior forebrain
of 6-week-old mice (2 mm from the anterior pole of the
brain). Dorsal SVZs were carefully dissected by using fine
scissors in the following dissociating medium: Earl’s
Balanced Salt Solution (Gibco, Invitrogen) supplemented
with 1 mg/ml Papain 27 U/mg (Sigma-Aldrich, St. Louis,
MO, USA), 0.2 mg/ml Cysteine (Sigma-Aldrich), and
0.2 mg/ml EDTA (Sigma-Aldrich). Then, dissected tissue
was incubated in the same solution for 30 min at 37 °C on
a rocking platform. Finally, dissociated cells were plated in
standard neurosphere growth medium Neurocult prolifer-
ation medium (Stemcell Technology, Vancouver, BC,
Canada) supplemented with epidermal growth factor
(EGF) (20 ng/ml) and fibroblast growth factor 2 (FGF2)
(10 ng/ml). For each in vitro passage, single cells were
obtained by incubating neurospheres in Accumax (Sigma-
Aldrich) for 10 min, and then 8000 cells/mm2 were
plated on T75 plastic flasks (Nunc, Rochester, NY,
USA). Neurospheres were propagated in vitro and
assayed for self-renewal and cell differentiation after six
passages, as previously described [28].
To label aNPCs, cells were transduced with a lenti-
virus [29] expressing green fluorescent protein (GFP);
about 1.5 × 106 cells in 10 ml were infected with 3 × 106
tu/ml of GFP-lentivirus. The day after the transduction,
the medium was replaced with a fresh one and cells
were allowed to grow. For LPS stimulation, aNPCs were
dissociated, incubated with 100 ng/ml of LPS (026:B6;
Sigma-Aldrich), and then collected after 16 h.
Cell culture electrophysiology
Whole-cell voltage-clamp recordings were performed on
mouse primary cortical neurons at 13–15 days in vitro.
During recordings, cells were bathed in a standard exter-
nal solution containing (in mM): 125 NaCl, 5 KCl, 1.2
MgSO4, 1.2 KH2PO4, 2 CaCl2, 6 glucose, and 25 HEPES-
NaOH, pH 7.4. Recording pipettes were fabricated from
borosilicate glass capillary by using a horizontal puller
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cing tip resistances of 3–5 MΩ and filled with a standard
intracellular solution containing (in mM): 130 K-gluco-
nate, 10 KCl,1 EGTA, 10 HEPES- NaOH, 2 MgCl2, 4
MgATP, and 0.3 Tris-GTP. For miniature excitatory post-
synaptic current (mEPSC) recordings, 1 μM tetrodotoxin,
20 μM Bicuculline, and 50 μM AP5 (Tocris Bioscience,
Bristol, UK) were added to standard extracellular solution
to block spontaneous action potential propagation,
GABA-A, and NMDA receptors, respectively. Recordings
were performed at room temperature in voltage clamp
mode at a holding potential of −70 mV by using a Multi-
clamp 700B amplifier (Molecular Devices, Sunnyvale, CA,
USA) and pClamp-10 software (Axon Instruments, Foster
City, CA, USA). Series resistance ranged from 10 to 20
MΩ and was monitored for consistency during record-
ings. Cells in culture with leak currents of more than 100
pA were excluded from the analysis. Signals were amp-
lified, sampled at 10 kHz, filtered to 2 or 3 KHz, and
analyzed by using pClamp 10 data acquisition and ana-
lysis program. To verify the specific effect of adult
NPCs, cultured cortical neurons were incubated for
24 h prior to electrophysiological recordings with either
lipopolysaccharide-stimulated (LPS+aNPCs) or unstimu-
lated aNPCs. Only cortical neurons surrounded by aNPCs
were selected to record.Immunofluorescence staining of dissociated neurons
Neuronal cultures were fixed with 4 % paraformaldehyde
and 4 % sucrose. The following antibodies were used:
rabbit anti-CB1 (1:500; Synaptic System, Goettingen,
Germany), guinea pig anti-vGLUT1 (1:1000; Synaptic Sys-
tem), and guinea pig anti -VGAT (1:750; Synaptic System).
Secondary antibodies were conjugated with Alexa-488 and
Alexa-555 fluorophores (Invitrogen).
Images were acquired by using a Leica Spe confocal
microscope equipped with an ACS APO 63.0X1.3 object-
ive (Leica, Wetzlar, Germany).
Pixel size was 94.8 nm_94.8 nm, and acquisition param-
eters (i.e., laser power, gain, and offset) were kept constant
across different experimental settings. The minimum
puncta size was set at three pixels.
Colocalization of two selected markers was measured
by using the boolean function “and” for the selected
channels. The resulting image was binarized, inverted,
and used as a colocalization mask to be subtracted
from single channel. The number of puncta resulting
from colocalization mask subtraction (colocalizing
puncta) was measured for each marker. A colocaliza-
tion ratio was set as colocalized area/total puncta aerea.
Fluorescence image processing and analyses were per-
formed with the ImageJ Software (National Institutes of
Health, Bethesda, MD, USA).Hoechst 33342/PI double-stain cell death detection essay
To distinguish between living and dead cell populations
and assess the percentage of neuronal death after AM251,
cultured neurons were incubated for 15 min at 37 °C with
Hoechst 33342 (final concentration, 1 ug/ml; Sigma-
Aldrich) and propidium iodide (PI) (final concentration,
1 μg/ml; Sigma-Aldrich) dissolved in neuronal medium.
PI is a red-fluorescence dye (excitation/emission maxima
~535/617 nm, when bound to DNA) which is only per-
meant to dead cells, whereas the blue-fluorescent Hoechst
33342 dye (excitation/emission maxima ~350/461 nm,
when bound to DNA) is specifically used to stain the
nuclei of living or fixed cells and tissues. Fluorescence im-
ages resulting from the simultaneous use of these dyes,
acquired by using an inverted Olympus IXB53 microscope
(Olympus, Tokyo, Japan), allowed us to determine the
number of dead neurons in our experimental conditions.
Statistical analysis
Patch clamp experiments were analyzed by using pClamp
10 data acquisition and analysis program and fluorescence
image processing and analyses were performed with the
ImageJ Software. Statistical analysis was performed by
using PRISM 6 software (GraphPad Software Inc., San
Diego, CA, USA). After testing whether data were nor-
mally distributed or not, the appropriate statistical test has
been used (see figure legends). n refers to the number of
elements analysed. Data are presented as mean ± standard
error of the mean from the indicated number of elements
analysed. The differences were considered to be significant
if P value of less was than 0.05 and are indicated by an as-
terisk; those at P value of less than 0.01 are indicated by
double asterisks.
Results
TNFα increases amplitude and frequency of miniature
currents in primary cortical neurons
Although several studies have shown that TNFα increases
synaptic strength at hippocampal excitatory synapses by
rapidly inserting AMPA receptors via TNFR1 receptor
activation [30], little has been reported in different neur-
onal cell types [31, 32]. To address whether this effect is
restricted to hippocampal neurons or also occurs at
cortical synapses, we grew cultures of primary neurons de-
rived from the cerebral cortex and exposed them to TNFα
(100 ng/ml) for 30 min before recording mEPSCs. Our
data showed a significant increase in both frequency and
amplitude of mEPSCs in TNFα-treated neurons with re-
spect to untreated control neurons (Fig. 1). This effect was
completely blocked in the presence of neutralizing TNFα
antibodies. These data indicate that cortical neurons re-
spond to TNFα in a manner that is similar to hippocampal
neurons and indicate that this cytokine may predispose
cortical neurons to excitotoxic phenomena.
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Fig. 1 TNFα increases mEPSC frequency and amplitude in cortical neurons. a Examples of voltage-clamp recordings of mEPSCs from cultured
cortical neurons in control conditions, upon treatment with TNFα (100 ng/ml 30 min) or in the presence of TNFα and neutralizing Abs (0.5 μg/ml;
R&D Systems) (calibration bars: 20 pA, 200 ms). b, c Group data of average mEPSC amplitude and frequency in untreated (n = 15), TNFα-treated
(n = 13), and TNFα plus neutralizing Ab-treated (n = 10) cells. A significant increase in average mEPSC amplitude and frequency is produced by
TNFα, completely blocked by neutralizing anti -TNFα Abs (P < 0.05). All data are expressed as mean ± standard error of the mean. Statistical test:
one-way analysis of variance, Dunn’s multiple comparisons test. Ab antibody, mEPSC miniature excitatory post-synaptic current, TNFα tumor necro-
sis factor alpha
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neurons
Both injury and neurodegenerative diseases increase the
amount of TNFα in the brain and this contributes to neur-
onal death. Recent studies demonstrated that SVZ-derived
aNPCs protect striatal neurons from glutamate-mediated
toxicity in pathological conditions associated with inflam-
mation and excitotoxicity, such as epilepsy and ischemic
stroke [24]. To assess whether the neuroprotective effects
of aNPCs extend to different neuronal types, we exposed
neurons to TNFα before or after incubating them for 24 h
with LPS+aNPCs in order to mimic the effects of different
danger (or recognition) signals triggering the inflamma-
tory response. aNPCs were infected in order to express
GFP [29], and only neurons surrounded by aNPCs were
selected to record (Fig. 2a). Notably, membranous struc-
tures of small and medium size, including round mem-
brane vesicles, were detected on the cell surface of aNPCs
(Fig. 2b left panel), as recently described [33]. Thesevesicles were released by aNPCs (Fig. 2b middle panel)
and adhered to GFP-negative neuronal cells (Fig. 2b right
panel).
Voltage clamp recordings of cortical neurons sur-
rounded by aNPCs revealed that the increase in average
mEPSC frequency due to TNFα was fully prevented by
treatment of the cultures with LPS+aNPCs (Fig. 2). A
clear tendency for recovery of mEPSC amplitude was
also observed, although statistical significance was not
reached. No difference in mEPSC frequency and ampli-
tude was detected when LPS+aNPCs were added to cell
cultures in the absence of TNFα (Fig. 2). Furthermore,
compared with striatal neurons where aNPCs exert a
regulatory role only when previously exposed to LPS
[24], both LPS-treated and LPS-untreated NPCs ap-
peared effective in preventing the changes in mEPSC
frequency and amplitude in cortical neurons following
TNFα administration. However, in the case of LPS-
untreated aNPCs, a statistically significant recovery was
AB
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Fig. 2 aNPCs treated with LPS prevent the increase in mEPSC frequency produced by TNFα in cortical neurons. a Representative fluorescence
microscopy images of cortical neurons incubated for 24 h with aNPCs either lipopolysaccharide-stimulated (LPS+aNPCs) or not (aNPCs) (green
cells). The right panel shows higher magnification (scale bar: 100 μm; 50 μm). Only cortical neurons surrounded by aNPCs were selected to
record (white arrows). b Details of (a) show GFP-positive membranous structures of small and medium size resembling round membrane
vesicles. c Representative traces of voltage-clamp recordings of mEPSCs from cultured cortical neurons in control conditions or from neurons
treated with LPS+aNPCs/aNPCs, TNFα, or LPS+aNPCs/aNPCs with TNFα (100 ng/ml 30 min) (calibration bars: 20 pA, 200 ms). d Group data of
average mEPSC amplitude and frequency of control (n = 15), LPS+aNPCs-treated (n = 12), aNPCs-untreated (n = 8), TNFα-treated (n = 13), LPS
+aNPC and TNFα-treated (n = 10), and aNPC-untreated and TNFα-treated (n = 8) cells. The increase in mEPSC frequency due to TNFα is completely
reverted by LPS+aNPCs (P < 0.05). The increase in mEPSC amplitude due to TNFα is completely reverted by aNPC treatment (P < 0.05). A clear, though
not significant, tendency toward reduction is detected in mEPSC amplitude or frequency in neuronal cultures exposed to LPS+aNPCs or aNPCs,
respectively. All data are expressed as mean ± standard error of the mean. Statistical test: one-way analysis of variance, Dunn’s multiple comparisons
test. aNPC adult neural stem cell, GFP green fluorescent protein, LPS lipopolysaccharide, LPS+aNPC lipopolysaccharide-stimulated adult neural stem cell,
mEPSC miniature excitatory post-synaptic current, TNFα tumor necrosis factor alpha
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dicate that aNPCs can revert the TNFα-induced mEPSC
alterations.
Adult neural stem/progenitor cells act via CB1 receptor
activation
The protective role of type 1 cannabinoid receptors (CB1),
against enhanced excitotoxic death caused by TNFα and
other harmful agents, has been demonstrated by several
studies [34, 35]. Furthermore, it has been found that
aNPCs are capable of secreting endogenous cannabinoids
[24, 36]. We therefore aimed to test whether, in our ex-
perimental conditions, aNPCs exert their described effect
through CB1 receptor activation. To this end, we recorded
mEPSCs in TNFα-treated cortical neurons incubated with
aNPCs in the presence of the CB1 antagonist AM251
(Fig. 3). The results showed that LPS+aNPC treatment
fails to revert TNFα effects in the presence of AM251, in-
dicating that aNPCs act through CB1 receptor activation.
As already shown in previous reports [37–39], CB1 recep-
tors were expressed mainly in inhibitory neurons (Fig. 3d)
and their localization did not change when neurons were
exposed to AM251 (Fig. 3e). Our results demonstrate that
CB1 is present in both inhibitory and excitatory synapses
but that the signal overlap is approximately 10 timeshigher in inhibitory synapses than in excitatory ones
(Fig. 3e). Additional file 1: Figure S1 shows that AM251
per se did not significantly change mEPSC frequency
and amplitude (A), did not display cytotoxic effects (B),
and did not change the synaptic expression of CB1
receptors (C, D).Discussion
TNFα plays a physiological role in controlling synaptic
transmission and plasticity in the healthy CNS by modu-
lating glutamate receptor trafficking to the plasma mem-
brane [2, 3]. Excitatory synapse scaling, caused by
blockade of neuronal activity, is known to be mediated by
TNFα which increases the insertion of AMPA receptors
(of both GluR1 and GluR2 subunits) into the plasma
membrane and decreases GABA-A receptor cell surface
expression. Through this process, TNFα increases the
mean frequency and amplitude of mEPSCs [31, 40, 41].
Consistently, in hippocampal cultures from TNFα-
deficient mice, no increase in mEPSC amplitude re-
sulted from activity blockade, thus confirming the
TNFα dependence of this increase [4]. In the present
study, we confirm the effects of TNFα in mEPSCs re-
corded from primary cultures of cortical neurons.
AD
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E
Fig. 3 The CB1 antagonist AM251 blocks the rescue of mEPSC changes sustained by LPS+aNPCs in TNFα-treated cultures. a Representative
electrophysiological traces of mEPSCs under the different treatment conditions. b, c Group data of average mEPSC amplitude and frequency
of untreated (n = 15), TNFα-treated (n = 13), LPS+aNPCs + TNFα (n = 10), and LPS+aNPCs + TNFα + AM 251-treated (n = 9) cells. LPS+aNPC
treatment fails to revert TNF effect in the presence of AM 251 (P < 0.05, P < 0.01). d Confocal microscopy images showing expression of CB1
receptor in cultured cortical neurons. Immunofluorescence for CB1 (green), VGAT (red), and Merge in the upper panels and for CB1 (green),
VGLUT (red) and Merge in lower panels is shown. Scale bars, 20 μm. e Summary bar graphs showing the colocalization of CB1 and VGAT or
VGLUT. All data are expressed as mean ± standard error of the mean. Statistical test: one-way analysis of variance, Dunn’s multiple comparisons
test. CB1 type 1 cannabinoid receptor, LPS+aNPC lipopolysaccharide-stimulated adult neural stem cell, mEPSC miniature excitatory post-synaptic current,
TNFα tumor necrosis factor alpha
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tissue injury and infection [42, 43]. Although astrocytes
and neurons are able to produce TNFα, microglial cells
are believed to be the major source of this cytokine dur-
ing neuroinflammation [44]. Through TNFR1 signaling,
TNFα promotes further cytokine release from microglia,
as well as increasing glutamate exocytosis and inhibiting
glutamate uptake from astrocytes, thus elevating extracel-
lular glutamate levels. Under such conditions, the TNFα-
mediated insertion of Ca2+ permeable-AMPA receptors
into the neuronal plasma membrane may cause excessive
Ca2+ influx into neurons and induce neuronal death. The
dying neurons maintain microglia in an active state,
releasing TNFα. Through this loop, TNFα provides a link
between neuroinflammatory and excitotoxic processes
(reviewed in [45]).
It has recently been shown that SVZ-derived aNPCs
play a role in protecting striatal medium spiny neuronsfrom glutamatergic excitotoxicity, by reverting the in-
creased frequency and duration of spontaneous excita-
tory post-synaptic currents induced by toxic or ischemic
stressful stimuli or both [24]. In the present study, we
demonstrate that aNPCs revert the effect of TNFα treat-
ment also in cortical neurons, fully preventing the
increase in mEPSC frequency. The increase in mEPSC
amplitude, a typical consequence of TNFα treatment [2],
was not observed in striatal neurons [24] where, besides
frequency, only half width and decay time of mEPSCs
were affected. Also, compared with previous work on
striatal tissue slices [24], where the addition of LPS-
exposed aNPCs, but not of untreated aNPCs, reverted
the EPSC changes produced by TNFα, both untreated
and LPS-treated aNPCs were effective in reverting either
the frequency or the amplitude of TNFα effects in cor-
tical neurons. These data indicate the existence of subtle,
but potentially significant, differences among different
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the potential protective effects of aNPCs.
Although we cannot exclude that factors other than
endocannabinoids may contribute to the observed
phenomenon, we show that aNPC effects on cortical
neurons are mediated by the activation of CB1 receptors,
as demonstrated by the blockade on aNSC-mediated re-
covery of TNFα effects by the CB1 antagonist AM251. It
is likely that the activation of CB1 receptors is a conse-
quence of the secretion of endocannabinod arachidonoyl
ethanolamide (AEA), a molecule that regulates gluta-
matergic tone through CB1 binding [24], by aNPCs.
Endocannabinoids are likely to be released from aNPCs
through extracellular membrane vesicles, which have been
recently found to allow the movement of lipophilic endo-
cannabinoids into the extracellular space to reach target
neurons [38]. Notably, in line with Cossetti and colleagues
[33], we have detected the formation of extracellular
vesicles from the cell surface of aNPCs. These vesicles ad-
here to the membrane of cortical neurons, thus support-
ing the concept that they may actively mediate the
communication of neural stem/precursor cells with the
microenvironment. It ensues from this that stem cell ther-
apies may work not only via cell replacement but also
through a consistent intercellular molecule exchange [33].
The preventive effect of aNPCs on the potentiation of
excitatory neurotransmission induced by TNFα in cortical
neurons may have important implications. Indeed, across
different pathological conditions, TNFα is thought to con-
tribute to neuroinflammation in AD. Aβ1–40 induces an
increase in TNFα expression and oxidative alterations in
the prefrontal cortex and hippocampus [46]. In support of
the role of TNFα as a central mediator of Aβ action,
excess cytokine, at a level 25 times higher than controls,
has been reported in the cerebrospinal fluid of patients
with AD, which correlates with progression from mild
cognitive impairment to AD [47]. Quite notably, a per-
centage of neurons localized near the plaques of amyloid
β deposits display unexpected hyperactivity [48, 49], which
might represent an early sign of neuronal excitotoxicity
associated with impending synaptic failure and incipi-
ent cognitive decline [50, 51]. In this respect, the pos-
sible protective role of aNPCs in mouse models of AD,
where TNFα is increased and neurons display hyper-
activity, deserves future investigation.Conclusions
We demonstrated that aNPCs revert the TNFα-induced
increase in frequency and amplitude of mEPSCs in cor-
tical neurons through the activation of CB1 receptors. By
preventing the potentiation of excitatory neurotransmis-
sion in cortical neurons, which represents the main target
for neurodegeneration in AD and other neurodegenerativepathologies, aNPCs may have significant translational
potential.
Additional file
Additional file 1: Figure S1. AM251 treatment has no effect on
synaptic activity, cell viability and CB1 receptor expression. A Representative
electrophysiological traces and group data of average mEPSC amplitude
and frequency of control (n = 10) and AM 251 treated (n = 9) cells (scale bar:
20 pA, 200 ms). B Fluorescence images of Hoechst and propidium iodide
double staining in cortical neurons and summary bar graph showing
lack of cytotoxic effects after AM251 treatment (scale bar: 40 μm). C, D
Confocal microscopy images and summary bar graph showing
expression of CB1 receptors in control and AM251 treated cultured
neurons (scale bar: 20 μm). All data are expressed as mean ± standard
error of the mean. CB1 type 1 cannabinoid receptor, mEPSC miniature
excitatory post-synaptic current. (PPT 1143 kb)
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